This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1995 Feb;80(2):342-5.

doi: 10.1210/jcem.80.2.7852486.

Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but..

A Pinchera¹, L Bartalena, C Marcocci

Affiliations

PMID: 7852486
DOI: 10.1210/jcem.80.2.7852486

Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but..

A Pinchera et al. J Clin Endocrinol Metab. 1995 Feb.

. 1995 Feb;80(2):342-5.

doi: 10.1210/jcem.80.2.7852486.

Authors

A Pinchera¹, L Bartalena, C Marcocci

Affiliation

¹ Istituto di Endocrinologia, University of Pisa, Tirrenia, Italy.

PMID: 7852486
DOI: 10.1210/jcem.80.2.7852486

No abstract available

PubMed Disclaimer

Similar articles

Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
Gorman CA. Gorman CA. J Clin Endocrinol Metab. 1995 Feb;80(2):340-2. doi: 10.1210/jcem.80.2.7852485. J Clin Endocrinol Metab. 1995. PMID: 7852485 No abstract available.
Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy.
Wartofsky L. Wartofsky L. J Clin Endocrinol Metab. 1995 Feb;80(2):347-9. doi: 10.1210/jcem.80.2.7852488. J Clin Endocrinol Metab. 1995. PMID: 7852488 No abstract available.
Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
DeGroot LJ, Gorman CA, Pinchera A, Bartalena L, Marcocci C, Wiersinga WM, Prummel MF, Wartofsky L, Marocci C [corrected to Marcocci C]. DeGroot LJ, et al. J Clin Endocrinol Metab. 1995 Feb;80(2):339-40. doi: 10.1210/jcem.80.2.7677823. J Clin Endocrinol Metab. 1995. PMID: 7677823 No abstract available.
Graves' ophthalmopathy and 131I therapy.
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A. Marcocci C, et al. Q J Nucl Med. 1999 Dec;43(4):307-12. Q J Nucl Med. 1999. PMID: 10731781 Review.
(131)I and thyroid-associated ophthalmopathy.
Rasmussen AK, Nygaard B, Feldt-Rasmussen U. Rasmussen AK, et al. Eur J Endocrinol. 2000 Aug;143(2):155-60. doi: 10.1530/eje.0.1430155. Eur J Endocrinol. 2000. PMID: 10913933 Review.

See all similar articles

Cited by

Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.
Moreno P, Gómez JM, Gómez N, Francos JM, Ramos E, Rafecas A, Jaurrieta E. Moreno P, et al. World J Surg. 2006 Nov;30(11):1950-6. doi: 10.1007/s00268-005-0770-x. World J Surg. 2006. PMID: 17006611
Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.
Marinò M, Chiovato L, Lisi S, Altea MA, Marcocci C, Pinchera A. Marinò M, et al. J Endocrinol Invest. 2004 Mar;27(3):230-6. doi: 10.1007/BF03345271. J Endocrinol Invest. 2004. PMID: 15164998 Review.
Relationship between management of hyperthyroidism and course of the ophthalmopathy.
Bartalena L, Tanda ML, Piantanida E, Lai A, Pinchera A. Bartalena L, et al. J Endocrinol Invest. 2004 Mar;27(3):288-94. doi: 10.1007/BF03345279. J Endocrinol Invest. 2004. PMID: 15165006 Review.
Controversial aspects of thyroid disease.
Hanna FW, Lazarus JH, Scanlon MF. Hanna FW, et al. BMJ. 1999 Oct 2;319(7214):894-9. doi: 10.1136/bmj.319.7214.894. BMJ. 1999. PMID: 10506049 Free PMC article. Review. No abstract available.
An update on medical management of Graves' ophthalmopathy.
Bartalena L, Marcocci C, Tanda ML, Piantanida E, Lai A, Marinò M, Pinchera A. Bartalena L, et al. J Endocrinol Invest. 2005 May;28(5):469-78. doi: 10.1007/BF03347230. J Endocrinol Invest. 2005. PMID: 16075933 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Research Materials
- NCI CPTC Antibody Characterization Program